Development and validation of an LC–MS/MS method for the simultaneous quantification of milbemycin oxime and praziquantel in plasma: application to a pharmacokinetic study in cats
IntroductionMilbemycin oxime (MBO) and praziquantel (PZQ) have a broad spectrum of biological activity and are commonly used to treat the parasitic infection in the veterinary clinic. In this study, a fast and efficient LC-MS/MS method was established and validated for the simultaneous determination...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Veterinary Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fvets.2023.1285932/full |
_version_ | 1797646810560331776 |
---|---|
author | Shiting Xie Shiting Xie Yixing Lu Yixing Lu Jun Wang Jun Wang Changcheng Lin Changcheng Lin Peiyu Ye Peiyu Ye Xiaolin Liu Wenguang Xiong Wenguang Xiong Zhenling Zeng Zhenling Zeng Dongping Zeng Dongping Zeng |
author_facet | Shiting Xie Shiting Xie Yixing Lu Yixing Lu Jun Wang Jun Wang Changcheng Lin Changcheng Lin Peiyu Ye Peiyu Ye Xiaolin Liu Wenguang Xiong Wenguang Xiong Zhenling Zeng Zhenling Zeng Dongping Zeng Dongping Zeng |
author_sort | Shiting Xie |
collection | DOAJ |
description | IntroductionMilbemycin oxime (MBO) and praziquantel (PZQ) have a broad spectrum of biological activity and are commonly used to treat the parasitic infection in the veterinary clinic. In this study, a fast and efficient LC-MS/MS method was established and validated for the simultaneous determination of MBO, PZQ, cis-4-hydroxylated-PZQ (C-4-OH-PZQ) and trans-4-hydroxylated-PZQ (T-4-OH-PZQ) and in cat plasma.MethodsExtraction of analytes and internal standards from cat plasma by acetonitrile protein precipitation, allows rapid processing of large batches of samples. MBO, PZQ, C-4-OH-PZQ, T-4-OH-PZQ, and internal standard (IS) were eluted for 13.5 min on a C18 column with a 0.1% formic acid water/acetonitrile mixture as the mobile phase.ResultsResults showed that the method had good precision, accuracy, recovery, and linearity. The linearity range was 2.5–250 ng/mL for MBO, and 10–1000 ng/mL for PZQ, C-4-OH-PZQ, and T-4-OH-PZQ. The intra-day and inter-day precision CV values of the tested components were within 15%. The extraction recoveries of the four components ranged from 98.09% to 107.46%. The analytes in plasma remained stable for 6 h at room temperature, 26 h in the autosampler (4 °C), after freeze–thaw (−20°C) cycles, and 60 days in a −20°C freezer. Method sensitivity sufficed for assessing pharmacokinetic parameters of MBO, PZQ, C-4-OH-PZQ, and T-4-OH-PZQ in plasma samples with LLOQ of 2.5 ng/mL for MBO and 10 ng/mL for PZQ, C-4-OH-PZQ, and T-4-OH-PZQ.ConclusionIn this study, a selective and sensitive LC-MS/MS method for the simultaneous quantification of MBO, PZQ, C-4-OH-PZQ, and T-4-OH-PZQ in cat plasma was developed and validated.This method had been successfully applied to evaluate the pharmacokinetics of MBO, PZQ, C-4-OH-PZQ, and T-4-OH-PZQ after a single oral administration of 8 mg MBO and 20 mg PZQ in cats. |
first_indexed | 2024-03-11T15:07:08Z |
format | Article |
id | doaj.art-c28a7b2d8ed647e8b36de42092b973dd |
institution | Directory Open Access Journal |
issn | 2297-1769 |
language | English |
last_indexed | 2024-03-11T15:07:08Z |
publishDate | 2023-10-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Veterinary Science |
spelling | doaj.art-c28a7b2d8ed647e8b36de42092b973dd2023-10-30T05:17:46ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692023-10-011010.3389/fvets.2023.12859321285932Development and validation of an LC–MS/MS method for the simultaneous quantification of milbemycin oxime and praziquantel in plasma: application to a pharmacokinetic study in catsShiting Xie0Shiting Xie1Yixing Lu2Yixing Lu3Jun Wang4Jun Wang5Changcheng Lin6Changcheng Lin7Peiyu Ye8Peiyu Ye9Xiaolin Liu10Wenguang Xiong11Wenguang Xiong12Zhenling Zeng13Zhenling Zeng14Dongping Zeng15Dongping Zeng16Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou, ChinaNational Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou, ChinaNational Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou, ChinaNational Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou, ChinaNational Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou, ChinaNational Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, Guangzhou, ChinaLivcare (Guangdong) Animal Health Co., Ltd, Qingyuan, ChinaGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou, ChinaNational Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou, ChinaNational Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou, ChinaNational Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, Guangzhou, ChinaIntroductionMilbemycin oxime (MBO) and praziquantel (PZQ) have a broad spectrum of biological activity and are commonly used to treat the parasitic infection in the veterinary clinic. In this study, a fast and efficient LC-MS/MS method was established and validated for the simultaneous determination of MBO, PZQ, cis-4-hydroxylated-PZQ (C-4-OH-PZQ) and trans-4-hydroxylated-PZQ (T-4-OH-PZQ) and in cat plasma.MethodsExtraction of analytes and internal standards from cat plasma by acetonitrile protein precipitation, allows rapid processing of large batches of samples. MBO, PZQ, C-4-OH-PZQ, T-4-OH-PZQ, and internal standard (IS) were eluted for 13.5 min on a C18 column with a 0.1% formic acid water/acetonitrile mixture as the mobile phase.ResultsResults showed that the method had good precision, accuracy, recovery, and linearity. The linearity range was 2.5–250 ng/mL for MBO, and 10–1000 ng/mL for PZQ, C-4-OH-PZQ, and T-4-OH-PZQ. The intra-day and inter-day precision CV values of the tested components were within 15%. The extraction recoveries of the four components ranged from 98.09% to 107.46%. The analytes in plasma remained stable for 6 h at room temperature, 26 h in the autosampler (4 °C), after freeze–thaw (−20°C) cycles, and 60 days in a −20°C freezer. Method sensitivity sufficed for assessing pharmacokinetic parameters of MBO, PZQ, C-4-OH-PZQ, and T-4-OH-PZQ in plasma samples with LLOQ of 2.5 ng/mL for MBO and 10 ng/mL for PZQ, C-4-OH-PZQ, and T-4-OH-PZQ.ConclusionIn this study, a selective and sensitive LC-MS/MS method for the simultaneous quantification of MBO, PZQ, C-4-OH-PZQ, and T-4-OH-PZQ in cat plasma was developed and validated.This method had been successfully applied to evaluate the pharmacokinetics of MBO, PZQ, C-4-OH-PZQ, and T-4-OH-PZQ after a single oral administration of 8 mg MBO and 20 mg PZQ in cats.https://www.frontiersin.org/articles/10.3389/fvets.2023.1285932/fullmilbemycin oximepraziquantelLC–MS/MScat plasmapharmacokinetics |
spellingShingle | Shiting Xie Shiting Xie Yixing Lu Yixing Lu Jun Wang Jun Wang Changcheng Lin Changcheng Lin Peiyu Ye Peiyu Ye Xiaolin Liu Wenguang Xiong Wenguang Xiong Zhenling Zeng Zhenling Zeng Dongping Zeng Dongping Zeng Development and validation of an LC–MS/MS method for the simultaneous quantification of milbemycin oxime and praziquantel in plasma: application to a pharmacokinetic study in cats Frontiers in Veterinary Science milbemycin oxime praziquantel LC–MS/MS cat plasma pharmacokinetics |
title | Development and validation of an LC–MS/MS method for the simultaneous quantification of milbemycin oxime and praziquantel in plasma: application to a pharmacokinetic study in cats |
title_full | Development and validation of an LC–MS/MS method for the simultaneous quantification of milbemycin oxime and praziquantel in plasma: application to a pharmacokinetic study in cats |
title_fullStr | Development and validation of an LC–MS/MS method for the simultaneous quantification of milbemycin oxime and praziquantel in plasma: application to a pharmacokinetic study in cats |
title_full_unstemmed | Development and validation of an LC–MS/MS method for the simultaneous quantification of milbemycin oxime and praziquantel in plasma: application to a pharmacokinetic study in cats |
title_short | Development and validation of an LC–MS/MS method for the simultaneous quantification of milbemycin oxime and praziquantel in plasma: application to a pharmacokinetic study in cats |
title_sort | development and validation of an lc ms ms method for the simultaneous quantification of milbemycin oxime and praziquantel in plasma application to a pharmacokinetic study in cats |
topic | milbemycin oxime praziquantel LC–MS/MS cat plasma pharmacokinetics |
url | https://www.frontiersin.org/articles/10.3389/fvets.2023.1285932/full |
work_keys_str_mv | AT shitingxie developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT shitingxie developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT yixinglu developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT yixinglu developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT junwang developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT junwang developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT changchenglin developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT changchenglin developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT peiyuye developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT peiyuye developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT xiaolinliu developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT wenguangxiong developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT wenguangxiong developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT zhenlingzeng developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT zhenlingzeng developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT dongpingzeng developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats AT dongpingzeng developmentandvalidationofanlcmsmsmethodforthesimultaneousquantificationofmilbemycinoximeandpraziquantelinplasmaapplicationtoapharmacokineticstudyincats |